SCHEMBL21036271

SCHEMBL21036271

O=C(O)[C@@H]1C[C@H](Oc2ccc(Cl)c(Oc3ccccc3)c2)CN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP9 P14780 2/20 0.42
MMP3 P08254 6/20 0.39
MMP1 P03956 5/20 0.39
MMP7 P09237 4/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
AKR1C3 P42330 4/20 0.38
MMP8 P22894 1/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA9 Q16790 1/20 0.37
AKR1C1 Q04828 1/20 0.37
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
ITGB1 P05556 1/20 0.36
ITGA4 P13612 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21036273 0.92 MMP9 (0.42) MMP9MMP3MMP1MMP7SMN1; SMN2
SCHEMBL21035405 0.92 MMP9 (0.42) MMP9MMP3MMP1MMP7SMN1; SMN2
SCHEMBL21035523 0.89 AKR1C3 (0.43) MMP9MMP3MMP1MMP7AKR1C3
SCHEMBL21036275 0.88 MMP9 (0.38) MMP9MMP3MMP1MMP7CA12
SCHEMBL21035407 0.88 MMP9 (0.38) MMP9MMP3MMP1MMP7CA12
SCHEMBL21034975 0.87 MMP9 (0.43) MMP9MMP3MMP1AKR1C3CA12
SCHEMBL21035657 0.87 MMP9 (0.43) MMP9MMP3MMP1AKR1C3CA12
SCHEMBL21035399 0.86 HTR1A (0.44) MMP9MMP3MMP1AKR1C3ITGB1
SCHEMBL21035314 0.86 HTR1A (0.44) MMP9MMP3MMP1AKR1C3ITGB1
SCHEMBL21035346 0.85 CA12 (0.48) MMP9MMP3MMP1AKR1C3CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed